Access cutting-edge inflammatory bowel disease treatment through this clinical trial at a research site in Cincinnati. Study-provided care at no cost to qualified participants.
Access inflammatory bowel disease specialists in Cincinnati at no cost
This study follows strict safety protocols and ethical guidelines
All study-related inflammatory bowel disease treatment provided free
Randomized, placebo-controlled dose-ranging study of 2'-FL in IBD, Crohn's Disease (CD) and ulcerative colitis (UC). The overarching hypothesis is that 2'-FL supplementation in IBD will be safe and well tolerated, while increasing fecal Bifidobacterium abundance and butyrate in a dose dependent manner. The investigators will test 1, 5, or 10 gm 2'-FL compared to 2 gm dextrose placebo as a daily dietary supplement in pediatric and young adult IBD participants in stable remission receiving inflixi
Sponsor: Children's Hospital Medical Center, Cincinnati
Check if you qualify for this inflammatory bowel disease clinical trial in Cincinnati, OH
If you're searching for inflammatory bowel disease treatment options in Cincinnati, OH, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Cincinnati research site is actively enrolling participants for this clinical trial. You'll receive care from experienced inflammatory bowel disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.